Latest worldwide news Detroit launches two-month review of city assets | | DETROIT (Reuters) - Detroit will begin to assess the value of its assets, including parking meters, real estate, and a portion of the Detroit Institute of Arts (DIA) collection, in what the city called a "necessary part" of its restructuring efforts. |
Rio's 'Big brother' tech | | Rio de Janeiro's state-of-the-art Operations Center is gathering real-time information on traffic jams and environmental emergencies around the clock. It's part of the mayor's vision to make the city safer and more sustainable. |
Sipping the Pleasures of Istria | | On a trip around this Croatian peninsula, the author renews his romance with a regional wine and discovers another culinary product to savor local olive oil. |
Peru plans cliff-edge hotel | | It's awkward, possibly ingenious; designers hope to create a building that will make Lima an international sensation. |
African alchemy to power U.S.? | | South African firm Sasol is building a $14 billion pant in Louisiana to turn natural gas into liquid fuels -- hailed as one of the biggest investments from a non-U.S. company in American history. |
Marikana An unresolved dispute | | Marikana lies on South Africa's platinum belt, where the world's richest deposits of the metal are located. Together with Russia, South Africa produces 90% of the world's platinum demand. The people of Marikana know the land is mineral rich, and last year they demanded a taste of that wealth. |
Japan's newest rocket fails to lift off | | TOKYO (Reuters) - Japan's first new rocket in 12 years failed to lift off on Tuesday, dealing a potential blow to hopes that Japan may be able to take a larger share of the growing, multi-billion dollar satellite launch industry. |
'Tell 'em about the dream, Martin' | | Martin Luther King, Jr.'s speech almost didn't even include its most memorable words. And, at first, there weren't any women invited to speak at the "freedom" march. |
China general's son in gang rape storm | | A gang rape allegedly involving the teenage son of a famous Chinese "singing general" has caused outrage in China, unleashing a tide of public anger over the behavior of so-called "princelings," the children of elite families. |
Outlook for PC shipments worsens IDC | | SAN FRANCISCO (Reuters) - The outlook for the struggling personal computer industry is worse than was previously believed, according to market research firm IDC, which on Thursday cut its 2013 forecast for global PC shipments for at least the second time. |
Public private partners come to potoroo rescue | | Aug. 25 - Australia's threatened long-nosed potoroo may be making a comeback in southeast Queensland thanks to a collaboration between government and private land-owners. The shy marsupial has been the victim of habitat destruction through land clearing but efforts by farmers are producing signs of recovery. Tara Cleary reports. |
Teenager defies the odds | | 17-year old Charley Hull will be the youngest player in Solheim Cup history after receiving a wildcard pick. |
Weak U.S. durable goods data dims growth outlook | | WASHINGTON (Reuters) - Orders for long-lasting U.S. manufactured goods recorded their biggest drop in nearly a year in July and a gauge of planned business spending on capital goods also tumbled,... |
Corgan Future of rock music | | Smashing Pumpkins singer Billy Corgan on why rock music needs God and how suffering isn't good for business. |
Serena I apologized to Maria | | Serena Williams refuses to get drawn into a pre-Wimbledon war of words with Maria Sharapova Sunday -- claiming she has apologized to her Russian rival for comments made about her personal life. |
Investing billions in the USA | | It may be far from home but a South African company is powering its way into the U.S. energy landscape, hoping that its grand plan to introduce a once-shunned technology in the United States will pay off. |
ThromboGenics earnings jump after new eye treatment launch | | BRUSSELS, Aug 29 (Reuters) - Belgian biomedical group ThromboGenics reported a 37 percent rise in revenue on Thursday on the back of sales of its main drug Jetrea, an eye treatment that was launched in both the United States and Europe this year. |
| |
Комментариев нет:
Отправить комментарий